Alentris Research Profile
Key Indicators
- Authorised Capital ₹ 3.10 M
- Paid Up Capital ₹ 3.10 M
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.08 M
- Revenue Growth 31.80%
- Profit Growth 5.70%
- Ebitda 4.79%
- Net Worth 442.73%
- Total Assets 197.13%
About Alentris Research
Alentris Research Private Limited (ARPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 18 May 2017 (Seven years and nine months 10 days old ). Its registered office is in Gandhi Nagar, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.10 M and a paid-up capital of Rs 3.10 M.
The company currently has active open charges totaling ₹7.08 M.
Hirenkumar Patel and Kirankumar Patel serve as directors at the Company.
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100GJ2017PTC097414
- Company No.
097414
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 May 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Alentris Research?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hirenkumar Patel  | Director | 17-Jun-2021 | Current |
| Kirankumar Patel | Director | 18-May-2017 | Current |
Financial Performance of Alentris Research.
Alentris Research Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 31.8% increase. The company also saw a slight improvement in profitability, with a 5.7% increase in profit. The company's net worth Soared by an impressive increase of 442.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alentris Research?
Unlock access to Alentris Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹7.08 M
₹0
Charges Breakdown by Lending Institutions
- Sidbi : 0.71 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Feb 2022 | Sidbi | ₹7.08 M | Open |
How Many Employees Work at Alentris Research?
Unlock and access historical data on people associated with Alentris Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alentris Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alentris Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
